Advertisement

Picture Fairtec GmbH Worldwide Event Solutions 600x60px

Deals > All

Find below collaborations, license and distribution agreements, grants, investments and loan agreements from Austria, Germany and Switzerland or involving organisations from these countries.

Total search results: 5562 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 43 44 45 ... 54 55 56  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Antisense Pharma–SEVERAL: investment, 201107 financing round €8m from MIG Funds + GAF 2011-07-06
Scienion–SQI Diagnostics: investment, 201107–201110 NOT REALISED acquisition CDN$15m in cash + 735k common shares of SQI 2011-07-04
Ballista–Stratec: investment, 201007 acquisition $5.2m with $4m in cash + $1.2m in treasury stock 2011-07-01
RTS Life Sciences–Brooks Automation: investment, 201107c acquisition by Brooks 2011-07-01
Metamark Genetics–Definiens: image analysis s/w, 201106– collab combination of multiplex protein detection with image analysis technology for cancer 2011-06-30
Scienion–Artel: liquid handling technology, 201106 supply use of Artel MVS to validate Scienion sciFLEXARRAYER 2011-06-30
Albany Molecular–Proteros: drug discovery services, 201106– collab strategic alliance joint offering of services to pharma industry 2011-06-28
NonWoTecc–SEVERAL: investment, 201106 2nd financing round €7m NRW.BANK + Rainer Christine +HTGF + KfW et al 2011-06-28
Bruker Corp–Univ Zurich: mass spectrometry, 201106– collab incl supply of MALDI Biotyper system to extend Biotyper reference library 2011-06-27
R-Biopharm–Scienion: print/spotting technology, 201106– supply use of sciFLEXARRAYER for production of planned »milkchip« 2011-06-27
Viollier–Bruker Corp: mass spectrometer, 201106– extension supply + agreement for use of MALDI Biotyper 2011-06-27
Euroimmun–EVP Capital: investment, 201106 existent portfolio company via Heptagon Capital listed on EVP web page 2011-06-26
Galantos–EVP Capital: investment, 201106 existent portfolio company listed on EVP web page 2011-06-26
Phenex–EVP Capital: investment, 201106 existent portfolio company listed on EVP web page 2011-06-26
Signature Diagnostics–EVP Capital: investment, 201106 existent portfolio company listed on EVP web page 2011-06-26
Coral BioNet–Germany (govt): grant, 201106 KMU Innovativ grant €0.9m from BMBF for evaluation of repellent proteins for RA to Scil Technology GmbH 2011-06-23
Enzymicals–Lonza: enzymes, 201106– global license for use of (R)-selective transaminases on laboratory scale 2011-06-21
Boehringer–Zealand Pharma: glucagon/GLP-1 dual agonist, 201106– collab + license ww excl incl ZP2929 with up to €376m milestones 2011-06-16
ACIB–Biokatalayse2021 Cluster: industrial biotechnology, 201106– strategic alliance 2011-06-15
Biofrontera–ASAT AG: investment, 201106–201108 investment in kind exchanging €2.094m debt claim into 385k new name shares 2011-06-15
Ipsogen–Qiagen: investment, 201106– offer to acquire 100% for €70m at €12.9/share 2011-06-15
Wiley–Medical Univ Innsbruck: MSforID Library, 201106 collab Wiley publishes MSforID as Wiley Registry of Tanden Mass Spectral Data 2011-06-14
ERC GmbH–Antec Leyden: ROXY EC system, 201106 distribution existent ERC is selling ROXY system in Germany 2011-06-08
Active Biotech–Evotec: drug discovery services, 201106– service €na medicinal chemistry services after successful HTS 2011-06-06
Max Planck–Rathmann Maschinenbau: machinery, 201106 supply MPI listed as reference customer 2011-06-02
Thermo Fisher–Rathmann Maschinenbau: machinery, 201106 supply Thermo Fisher Scientific listed as reference customer 2011-06-02
Vacutec–Rathmann Maschinenbau: machinery, 201106 supply Vacutec Hochvakuum listed as reference customer 2011-06-02
Galapagos–Burrill: financial services, 201106 supply Burrill Merchant Banking acted as financial advisor for sale of Compound Focus to Evotec 2011-06-01
Galapagos–Evotec: investment, 201106 acquisition 100% of Compound Focus Inc for €10.25m cash upfront + €2.25m milestones by Evotec 2011-06-01
GSG Mess- und Analysengeräte–Prosolia: OmniSpray DESI ion source, 201105– distribution + marketing excl in DE + CH + AT by GSG 2011-05-31
Wiley–GeneBio: SmileMS software, 201105– collab ww non-excl co-distribution of SmileMS with LC-MS/MS libraries 2011-05-30
Bayer–Epitomics: RabMab technology, 201105– supply use of RabMab for antibodies for drug target identification + validation at Bayer Schering Pharma 2011-05-26
Genkyotex–LCF Rothschild: investment, 201105 financing round Series C totalling CHF18m=$20.4m incl lead investor EdRIP 2011-05-24
Genkyotex–SEVERAL: investment, 201105 financing round Series C CHF18m=$20.4m led by EdRIP 2011-05-24
Prometheus–Nestlé: investment, 201105 acquisition €na by Nestlé Health Science SA 2011-05-24
Siemens–Bruker Corp: mass spectrometer, 201105– collab strategic alliance co-marketing of MALDI Biotyper for proteomic fingerprinting 2011-05-23
Analyticon Discovery–Sobera Capital: investment, 201105 existent listed as portfolio company at web site 2011-05-20
Biobase–Sobera Capital: investment, 201105 existent listed as portfolio company at web site 2011-05-20
Sepiatec–Sobera Capital: investment, 201105 existent listed as portfolio company at web site 2011-05-20
Nycomed–Takeda: investment, 201105 acquisition €9.6b from private equity funds on cash + debt free basis announced 2011-05-19
Themis Bioscience–SEVERAL: investment, 201105 financing round Series A €5m co-led by Ventech + Crédit Agricole Private Equity 2011-05-18
Curetis–Akampion: public relations, 201105 service existent 2011-05-17
Curetis–SEVERAL: investment, 201105 financing round Series A extension additional €6m new investor CD-Venture + existing investors 2011-05-17
Analytisches Zentrum Biopharm–Agilent: mass spectrometer, 201105 supply existent Agilent 1100 MSD LC/MS system listed on web site 2011-05-15
Analytisches Zentrum Biopharm–Agilent: mass spectrometer, 201105 supply existent Agilent GC/MS system listed on web site 2011-05-15
Analytisches Zentrum Biopharm–Bruker Corp: mass spectrometer, 201105 supply existent Esquire 3000+ LC/MS system listed on web site 2011-05-15
Analytisches Zentrum Biopharm–Danaher: mass spectrometer, 201105 supply existent API 4000 LC/MS system listed on web site 2011-05-15
MYR GmbH–High-Tech Gründerfonds: investment, 201105 HTGF invests €500k 2011-05-12
Aperio–Definiens: image analysis s/w, 201105– collab co-marketing ww non-excl Definiens Tissue Studio with Aperio’s digital pathology solutions 2011-05-10
Klinikum Bayreuth–Bruker Corp: mass spectrometer, 201105 supply existent MADLI Biotyper ID integrated w BD Phoenix system 2011-05-08
Université Catholique de Louvain–Bruker Corp: mass spectrometer, 201105 supply existent MADLI Biotyper ID integrated w BD Phoenix system at Saint-Luc 2011-05-08
Vatican Hospital–Bruker Corp: mass spectrometer, 201105 supply existent MADLI Biotyper ID integrated w BD Phoenix system 2011-05-08
Epigenomics–Life Technologies: Dynabeads, 201105– supply Dynabeads MyOne SILANE for Epi proColon 2.0 by Invitrogen Dynal AS 2011-05-06
JnJ–Cenix BioScience: siRNA technology, 201105– collab + technology license agreem incl co-developm of DARE siRNA delivery techn Janssen Pharmaceutica 2011-05-04
Protectimmun–High-Tech Gründerfonds: investment, 201105 1st financing round totalling €1.3m incl HTGF + ELS-Fonds + KfW 2011-05-04
Protectimmun–SEVERAL: investment, 201105 1st financing round €1.3m investors HTGF + ELS-Fonds + KfW 2011-05-04
CCS Cell Culture Service–InSphero: cell culture technology, 201105– collab commercial incl product integration 2011-05-03
Delenex–SEVERAL: investment, 201105 financing round series A extension of addit CHF16.7m (€13m) lead + new investor Novo Ventures 2011-05-03
Transcatheter Technologies–High-Tech Gründerfonds: investment, 201105 financing round Series A totalling €1.7m incl returning co-investor HTGF 2011-05-03
Transcatheter Technologies–SEVERAL: investment, 201105 financing round Series A €1.7m lead investor Rolf Käse 2011-05-03
Evolva–Publicis: public relations, 201105 service existent by Capital MSL 2011-05-02
Dako–Tecan: Dako Omnis staining platform, 201105– supply OEM by Tecan 2011-05-01
Marine Fungi project–EU (govt): grant, 201105–201404 FP7 grant €3m 2011-05-01
Marine Fungi project–Evotec: drug discovery, 201105–201404 project partner for screening is European ScreeningPort GmbH 2011-05-01
Marine Fungi project–Leibniz-Gemeinschaft: drug discovery, 201105–201404 project partner + co-ordinator KiWiz Kieler Wirkstoffzentrum 2011-05-01
Co.don–SEVERAL: investment, 201104 capital increase €1.07m net €1m 1.07m new common shares €1/share 2011-04-29
Biocon–Axicorp: investment, 201104 management buy-out of 78% of Axicorp from Biocon for €40m 2011-04-28
Silence Therapeutics–SEVERAL: investment, 201104–201105 institutional placing + open offer £5.9m 275m+21.7m new ordinary shares 2p/share 2011-04-27
Evotec–ROI Verwaltungsgesellschaft: investment, 201104 existent ROI owns 17.4m voting rights or 15.07% of voting rights 2011-04-20
Protagen–Scienion: protein microarrays, 201104– service supply of protein microarray batches to Protagen using sciFLEXARRAYER 2011-04-19
Scienion–Protagen: print/spotting technology, 201104– collab co-developm proteomic applications of sciFLEXARRAYER technology for diagnostics + pharma 2011-04-19
Bayer–Max Planck: cancer drug, 201104– license ww excl to lead structure from Lead Discovery Center €na upfront + up to 137.5m milestones + royalties 2011-04-18
Integrated Diagnostics–Biognosys: proteomic services, <=201104 supply service using Targeted Proteomics technolgoy to identify + quantify proteins 2011-04-18
Novartis–Biognosys: proteomic services, 201104– supply service Targeted Proteomics techn for undisclosed discovery area of Novartis Vaccines Siena 2011-04-18
Pfizer–Biognosys: proteomic services, <=201104 supply service using Targeted Proteomics technolgoy to identify + quantify proteins 2011-04-18
Philips–Biognosys: proteomic services, <=201104 supply service using Targeted Proteomics technolgoy to identify + quantify proteins 2011-04-18
Danaher–Definiens: image analysis s/w, 201104– collab co-marketing Definiens XD s/w with Leica microscopy hardware 2011-04-14
Jacobs Univ–Roche: xCELLigence system, 201104– supply existent used by Brix group in School of Engineering and Science 2011-04-14
F-Star–SEVERAL: investment, 201104 financing round €15m lead investor SR One + investments by all existing investors 2011-04-13
Daiichi Sankyo–Pieris: Anticalin scaffold technology, 201104– collab €7m upfront + up to €200m + royalties drug discovery Anticalins for 2 targets 2011-04-12
Abunda Nutrition–Evolva: investment, 201104– acquisition merger announced for 25m shares = 12.9% post transaction, fully diluted 2011-04-05
Cellestis–Qiagen: investment, 201104–201108 acquisition $374m 2011-04-04
Corning–Eppendorf: gradient PCR technology, 201104 license to Labnet International incl US Patents 6767512 + 7074367 2011-04-04
Roche–Eppendorf: gradient PCR technology, 201104 license to F Hoffman-La Roche Ltd incl US Patents 6767512 + 7074367 2011-04-04
Beun-de Ronde–SAW Instruments: acoustic biosensor, 201104– distribution of sam biosensors in NL by Beun-de Ronde BV 2011-04-01
Bruker Corp–Germany (govt): grant, 201104–201403 grant €409k to Bruker Daltonik GmbH in MALDI-AMK 3D MALDI Imaging project from BMBF 2011-04-01
eADMET–SEVERAL: investment, 201104c seed financing round from High-Tech Gründerfonds + Bayern Kapital 2011-04-01
Fraunhofer–Germany (govt): grant, 201104–201403 grant €287k to Fraunhofer MEVIS in MALDI-AMK 3D MALDI Imaging project from BMBF 2011-04-01
Univ Bremen–Germany (govt): grant, 201104–201403 grant €226k to Zentrum für Technomathematik in MALDI-AMK 3D MALDI Imaging project from BMBF 2011-04-01
Acacia Pharma–Gilde Investment: investment, 201103 financing round Series A totalling $10m incl existing investor Gilde Healthcare 2011-03-31
Acacia Pharma–Lundbeck: investment, 201103 financing round Series A totalling $10m incl new investor Lundbeckfond Ventures 2011-03-31
Acacia Pharma–SEVERAL: investment, 201103 financing round Series A $10m from new investor Lundbeckfond Ventures + existing investor Gilde Healthcare 2011-03-31
Advanced Cell Diagnostics–Definiens: image analysis s/w, 201103– collab developm biomarker analysis solutions build on RNAscope platform 2011-03-31
BioVersys–SEVERAL: investment, 201103 seed financing round CHF2.5m led by EVA + joined by private investors out of BioBAC 2011-03-31
Definiens–Ricochet Public Relations: public relations, 201103 service existent 2011-03-31
General Electric–Ricochet Public Relations: public relations, 201103 service existent for GE Healthcare 2011-03-31
Newron–Merck (DE): CNS drugs, 201103– developm license €na for pruvanserin + sarizotan from Merck Serono with buy-back option for Merck Serono 2011-03-31
Sigma-Aldrich–Ricochet Public Relations: public relations, 201103 service existent 2011-03-31
Univ York–Bruker Corp: mass spectrometer, 201103 supply existent apex ultra Qh-FTMS at Centre of Excellence in Mass Spectrometry 2011-03-31
Univ York–Bruker Corp: mass spectrometer, 201103 supply existent esquire 6000 ion trap at Centre of Excellence in Mass Spectrometry 2011-03-31
next pagenext page 1 2 3 ... 43 44 45 ... 54 55 56  next pagenext page



Advertisement

Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

» top